Onconova Therapeutics Inc. (ONTX) Trading 3.2% Higher
Onconova Therapeutics Inc. (NASDAQ:ONTX) shares traded up 3.2% during mid-day trading on Friday . The company traded as high as $3.69 and last traded at $3.60, with a volume of 257,658 shares trading hands. The stock had previously closed at $3.49.
Separately, Maxim Group set a $6.00 target price on Onconova Therapeutics and gave the company a “buy” rating in a research report on Thursday. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $24.74.
The stock’s market cap is $9.89 million. The firm’s 50-day moving average price is $4.40 and its 200 day moving average price is $4.85.
Onconova Therapeutics (NASDAQ:ONTX) last announced its quarterly earnings data on Thursday, May 12th. The biopharmaceutical company reported ($0.27) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.19) by $0.08. Equities research analysts forecast that Onconova Therapeutics Inc. will post ($7.40) earnings per share for the current fiscal year.
Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways important to cancer cells. It has three clinical-stage product candidates and many preclinical programs that target kinases, cellular metabolism or cell division.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.